VOLITIONRX LTD
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
VNRX$0.18-7.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(Expressed in United States Dollars, except share numbers)
| For the Years Ended | ||
|---|---|---|
| December 31, 2023 | December 31, 2022 | |
| $ | ||
| Revenues | ||
| Royalty | 1,369 | 2,911 |
| Service | 175,476 | 92,488 |
| Product | 598,457 | 210,993 |
| Total Revenues | 775,302 | 306,392 |
| Operating Expenses | ||
| Research and development | 19,551,523 | 15,332,989 |
| General and administrative | 10,368,314 | 10,177,229 |
| Sales and marketing | 6,843,160 | 6,576,246 |
| Total Operating Expenses | 36,762,997 | 32,086,464 |
| Operating Loss | (35,987,695) | (31,780,072) |
| Other Income (Expenses) | ||
| Grant income | 214,451 | 1,229,425 |
| Loss on disposal of fixed assets | (15,843) | - |
| Interest income | 93,324 | 125,265 |
| Interest expense | (221,622) | (173,087) |
| Gain on change in fair value of warrant liability | 240,311 | - |
| Total Other Income | 310,621 | 1,181,603 |
| Net Loss | (35,677,074) | (30,598,469) |
| Net Loss attributable to Non-Controlling Interest | 357,996 | 329,676 |
| Net Loss attributable to VolitionRx Limited Stockholders | (35,319,078) | (30,268,793) |
| Other Comprehensive Income (Loss) | ||
| Foreign currency translation adjustments | 16,843 | 78,771 |
| Net Comprehensive Loss | (35,660,231) | (30,519,698) |
| Net Loss Per Share – Basic and Diluted attributable to VolitionRx Limited Stockholders | (0.50) | (0.55) |
| Weighted Average Shares Outstanding | ||
| – Basic and Diluted | 71,234,565 | 55,350,401 |
| (The accompanying notes are an integral part of these consolidated financial statements) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.